{"id":258376,"date":"2026-09-21T10:04:45","date_gmt":"2026-09-21T04:34:45","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=258376"},"modified":"2026-09-21T10:04:45","modified_gmt":"2026-09-21T04:34:45","slug":"why-mankind-pharma-ltd-share-price-price-rise-2026-09-21","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/","title":{"rendered":"Mankind Pharma Ltd. (MANKIND): Mankind Pharma Share Price rises 3% on Rs 95,743.85 crore market cap"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma Ltd. (MANKIND)<\/a> share price rose to Rs 2,387.5 today, up 3% from the previous close. Market cap was Rs 95,743.85 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 21 September 2026 at 9:49:56 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Mankind Pharma Share Price rose today to Rs 2,387.50, up 3% from the previous close of Rs 2,318. The stock added Rs 69.50 during the session and ended close to the day\u2019s high of Rs 2,389 after opening at Rs 2,303.05. Mankind Pharma Ltd. now carries a market capitalisation of Rs 95,743.85 crore, placing the move in a large listed healthcare business context. The supplied data confirms the price event, while it does not establish a company-specific catalyst. For readers tracking Mankind Pharma Share Price Today, the main facts are the day\u2019s move, the session range and the valuation backdrop. Univest is useful here because it brings together live share price, financial ratios, peer context and company-specific stock news in one place.<\/p>\n<p>The broader relevance of Mankind Pharma Share Price Today is that the stock moved with a relatively modest turnover of Rs 2.87 crore, without any verified operational trigger in the supplied data. That makes the day\u2019s stock news more about the price move itself, and less about a fresh corporate development. Investors following Mankind Pharma Stock News can therefore focus on the company\u2019s current valuation, earnings profile and comparison with healthcare peers rather than assuming a new event-driven reason.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Mankind_Pharma_Share_Price_Today_Price_Action_Analysis\" title=\"Mankind Pharma Share Price Today: Price Action Analysis\">Mankind Pharma Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Mankind_Pharma_Ltd_MANKIND_Fundamental_Analysis\" title=\"Mankind Pharma Ltd. (MANKIND) Fundamental Analysis\">Mankind Pharma Ltd. (MANKIND) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Why_Investors_Are_Watching_Mankind_Pharma\" title=\"Why Investors Are Watching Mankind Pharma\">Why Investors Are Watching Mankind Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#About_Mankind_Pharma\" title=\"About Mankind Pharma\">About Mankind Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Track_Mankind_Pharma_Share_Price_on_Univest\" title=\"Track Mankind Pharma Share Price on Univest\">Track Mankind Pharma Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Why_did_Mankind_Pharma_Share_Price_rise_today\" title=\"Why did Mankind Pharma Share Price rise today?\">Why did Mankind Pharma Share Price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#What_is_Mankind_Pharma_Share_Price_today\" title=\"What is Mankind Pharma Share Price today?\">What is Mankind Pharma Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#What_is_Mankind_Pharmas_market_capitalisation\" title=\"What is Mankind Pharma\u2019s market capitalisation?\">What is Mankind Pharma\u2019s market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#How_is_Mankind_Pharma_valued_compared_with_peers\" title=\"How is Mankind Pharma valued compared with peers?\">How is Mankind Pharma valued compared with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#What_do_Mankind_Pharmas_EPS_and_book_value_show\" title=\"What do Mankind Pharma\u2019s EPS and book value show?\">What do Mankind Pharma\u2019s EPS and book value show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#How_does_Mankind_Pharma_compare_with_the_healthcare_sector\" title=\"How does Mankind Pharma compare with the healthcare sector?\">How does Mankind Pharma compare with the healthcare sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-mankind-pharma-ltd-share-price-price-rise-2026-09-21\/#Where_can_I_track_Mankind_Pharma_Share_Price_Live\" title=\"Where can I track Mankind Pharma Share Price Live?\">Where can I track Mankind Pharma Share Price Live?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Mankind_Pharma_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Mankind Pharma Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,387.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,318<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 69.5 (+3%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,303.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,389<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,302.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.87 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 95,743.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) rose to Rs 2,387.5 from the previous close of Rs 2,318, a move of Rs 69.5 or 3%. The stock opened at Rs 2,303.05, reached a high of Rs 2,389, recorded a low of Rs 2,302.3.<\/p>\n<p>Mankind Pharma Share Price moved from the previous close of Rs 2,318 to Rs 2,387.50, a gain of Rs 69.50 or 3%. The stock opened at Rs 2,303.05, touched a low of Rs 2,302.30 and a high of Rs 2,389. The day\u2019s move shows a clear positive session within the supplied range, and the closing price finished very near the session high. For users checking Mankind Pharma Share Price Live or Mankind Pharma Share Price Update, today\u2019s data is straightforward: price rose, market capitalisation remained at Rs 95,743.85 crore and turnover stood at Rs 2.87 crore. Univest records the same-day price rise without assigning a cause that is not present in the data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mankind_Pharma_Ltd_MANKIND_Fundamental_Analysis\"><\/span><strong>Mankind Pharma Ltd. (MANKIND) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 95,743.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 49.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 407.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.04%<\/td>\n<\/tr>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) fundamental metrics show P\/E 46.87x, P\/B 5.69x, ROE 12.69%, ROCE 13.24%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Mankind Pharma Ltd. has a market capitalisation of Rs 95743.85 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 46.87x, P\/B at 5.69x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.4x to 683.5x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">5.69x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.08x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.46%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 95,743.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 701.78 crore<\/td>\n<\/tr>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Mankind Pharma Ltd. (MANKIND) has a P\/E ratio of 46.87x, which is above the benchmark median of 32.87x, a difference of +42.59%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.7%, a difference of +8.46%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is below the benchmark median of 13.46%, a difference of -1.63%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,40,397.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,48,664.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">85.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,82,738.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,012.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,10,793.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Mankind Pharma Ltd. (MANKIND) has a P\/E ratio of 46.87x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 95,743.85 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Mankind_Pharma\"><\/span><strong>Why Investors Are Watching Mankind Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Mankind Pharma Share Price rose 3% to Rs 2,387.50 from the previous close of Rs 2,318.<\/li>\n<li>The stock\u2019s session high was Rs 2,389, while the low was Rs 2,302.30.<\/li>\n<li>Market capitalisation stood at Rs 95,743.85 crore on the day.<\/li>\n<li>P\/E was 46.87 and P\/B was 5.69, both above the industry median.<\/li>\n<li>ROE was 12.69% and ROCE was 13.24%, which keeps Mankind Pharma Stock Analysis relevant for sector comparison.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Mankind_Pharma\"><\/span><strong>About Mankind Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mankind Pharma Ltd. operates in the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. The company is followed in Indian Stock Market discussions because it is a large listed pharma business with a market cap of Rs 95,743.85 crore and regular coverage in Mankind Pharma Stock News. Its business is associated with pharma products and the broader healthcare category, making Mankind Pharma Share Price relevant to readers tracking sector-wide stock updates.<\/p>\n<p>From a financial analysis perspective, the company\u2019s reported EPS of Rs 49.45, book value of Rs 407.39 and dividend yield of 0.04% give a simple earnings-and-capital base view of the business. Univest presents these data points alongside the share price so readers can connect company overview, valuation and stock performance in one place. The stock also sits within a peer set that includes Sun Pharma, Divi\u2019s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Cipla, Lupin and Dr. Reddy\u2019s Laboratories.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Mankind_Pharma_Share_Price_on_Univest\"><\/span><strong>Track Mankind Pharma Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/mankind\/mankind-pharma-ltd-share-price-today\">Mankind Pharma Ltd. (MANKIND) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Investors can track Mankind Pharma Share Price on Univest for live price updates, key financial ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers review Mankind Pharma Share Price Today alongside peer comparison, sector context and broader stock market today coverage. For Mankind Pharma Stock Gaining Today, the platform keeps price, valuation and company news in one view.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Mankind_Pharma_Share_Price_rise_today\"><\/span><strong>Why did Mankind Pharma Share Price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Mankind Pharma Share Price rose 3% to Rs 2,387.50, but it does not establish a company-specific catalyst. The day\u2019s facts are price, range, turnover and market cap.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Mankind_Pharma_Share_Price_today\"><\/span><strong>What is Mankind Pharma Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma Share Price today is Rs 2,387.50. It moved up Rs 69.50, or 3%, from the previous close of Rs 2,318 and finished near the day\u2019s high of Rs 2,389.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Mankind_Pharmas_market_capitalisation\"><\/span><strong>What is Mankind Pharma\u2019s market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma\u2019s market capitalisation is Rs 95,743.85 crore. That places it well above the same-industry median and gives context to Mankind Pharma Share Price when compared with other healthcare names.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Mankind_Pharma_valued_compared_with_peers\"><\/span><strong>How is Mankind Pharma valued compared with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mankind Pharma trades at a P\/E of 46.87 and P\/B of 5.69. That is above the industry median on both metrics and below some premium peers such as Divi\u2019s Laboratories and Torrent Pharmaceuticals.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Mankind_Pharmas_EPS_and_book_value_show\"><\/span><strong>What do Mankind Pharma\u2019s EPS and book value show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> EPS is Rs 49.45 and book value is Rs 407.39. EPS indicates earnings attributable to each share, while book value shows accounting net worth per share, both useful for Mankind Pharma Stock Analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Mankind_Pharma_compare_with_the_healthcare_sector\"><\/span><strong>How does Mankind Pharma compare with the healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the supplied same-industry benchmark, Mankind Pharma\u2019s P\/E is above the median but below the average. Its ROE is above the median, while ROCE sits slightly below the median, giving mixed sector context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Mankind_Pharma_Share_Price_Live\"><\/span><strong>Where can I track Mankind Pharma Share Price Live?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can track Mankind Pharma Share Price Live on Univest, where the stock page brings together current price, ratios, shareholding pattern, 52-week levels and company news in one place for quick reference.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mankind Pharma Ltd. Share Price rises to Rs 2,387.5. marking a 3% rise today. Market cap stands at Rs 95,743.85 crore.<\/p>\n","protected":false},"author":29,"featured_media":258374,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-258376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["258374"],"rank_math_title":["Mankind Pharma Share Price today: healthcare sector analysis"],"rank_math_description":["Mankind Pharma Share Price rose 3% to Rs 2,387.50, with market cap at Rs 95,743.85 crore. See price action, valuation and sector context."],"rank_math_focus_keyword":["Mankind Pharma Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Mankind_Pharma_Ltd_MANKIND_Mankind_Pharma_Share_Price_rises_3_on_Rs_9574385_crore_market_cap_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/258376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=258376"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/258376\/revisions"}],"predecessor-version":[{"id":258377,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/258376\/revisions\/258377"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/258374"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=258376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=258376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=258376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}